Nilotinib treatment-associated accelerated atherosclerosis: when is the risk justified?

類似資料

• When is treatment for cancer economically justified?
  著者:: Svoboda, V
  出版事項: (1990)
• When is treatment economically justified?
  著者:: Sizer, B
  出版事項: (1991)
• When calculation of minimum sample size is not justified: When sample size calculation is not justified
  著者:: Pourhoseingholi, Mohamad Amin, 等
  出版事項: (2011)
• When is treatment for cancer economically justified?
  著者:: Berlin, J
  出版事項: (1990)
• When is operative treatment justified in the treatment of fractures of the long bones?
  著者:: Scudder, Charles L.
  出版事項: (1926)